Explore the complete record of transactions filed by ANNE-SOPHIE LARIVIERE, Vice President, Strategy & Operational Excellence. Insider active across 1 companies, notably NANOBIOTIX. Cumulatively, 1 filings have been logged. The latest transaction was filed on 27 June 2025 — ATTRIBUTION GRATUITES D'ACTIONS. Regulator: AMF. All data is openly available.
1 of 1 declaration
Anne-Sophie Larivière is the Vice President, Strategy & Operational Excellence at Nanobiotix, a French listed biotechnology company focused on physics-based nanotherapeutics. She brings more than ten years of experience spanning strategic consulting and the life sciences industry, with a career shaped by international exposure, market strategy, and cross-functional execution. At Nanobiotix, she contributes to strategic alignment, operational performance, and organizational effectiveness, supporting the company in a highly demanding environment where clinical development, corporate priorities, and execution discipline must remain closely connected. Her role is particularly relevant in a biotechnology setting, where decisions around resources, timing, and external communication can materially influence value creation. Before joining Nanobiotix, Anne-Sophie Larivière began her career in Singapore at Sanofi, gaining early experience in a major pharmaceutical group and building an international perspective. She later joined Bionest Partners, a strategic consulting boutique specialized in life sciences, where she helped U.S. biotechnology companies design their European commercialization strategies. During that period, she also worked with large pharmaceutical companies, medtech firms, and investment funds, strengthening her expertise in go-to-market strategy, market access thinking, and business development support. In 2017, she joined MedDay Pharmaceuticals, a French biotech developing drug candidates in neurodegenerative diseases. There, she held several positions, progressing from Launch Project Manager to Strategic Marketing Director and later Value Strategy Director. Across these responsibilities, she worked across functions to coordinate teams, align stakeholders, and facilitate execution throughout the organization. Her last role also included external corporate communication and transaction preparation, highlighting her ability to bridge strategy, messaging, and operational readiness. Anne-Sophie Larivière is an engineer by training, having graduated from ESCOM and ENSIC, and she also holds a specialized master’s degree from ESCP Europe. Her profile reflects a strong combination of strategic thinking, operational rigor, and life sciences expertise, making her well suited to leadership roles in innovative biotechnology companies.